Category Archives: Pradaxa

Featured Stories

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Pradaxa®, Other New Blood Thinners Can Triple Bleeding Risks in ACS Patients, Study Finds

A study of new blood thinners, including Pradaxa®, has found that these novel drugs pose an elevated bleeding risk that cancels out their benefits in patients with Acute Coronary Syndrome (ACS).  According to a report from MedPage Today, the study … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Finds New Blood Thinner Hasn’t Had Much Effect on Treatment of Atrial Fibrillation

A new Pradaxa study conducted by U.S. researchers has found that Pradaxa hasn’t really changed the way doctors treat atrial fibrillation, its approved indication.  According to a report from the UPI, the same study also found that a growing number … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Sees Higher Bleeding, Clot Risk after Atrial Fibrillation Ablation

A study published in February reported that patients who took Pradaxa (dabigatran) following radiofrequency ablation to treat atrial fibrillation experienced more bleeding and blood clots compared to people who were treated with warfarin post-procedure.  The authors of the study, published … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuits To Proceed “Expeditiously,” Federal Judge Promises

A total of 78 Pradaxa bleeding lawsuits are now pending in the multidistrict litigation in U.S. District Court, Southern District of Illinois.  According to a report from The Madison Record, U.S. District Judge David Herndon has scheduled the Pradaxa litigation’s … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa, Other Dangerous Drugs Make it to Market Thanks to Quick FDA Approvals

A new study has questioned the Food and Drug Adminstration’s (FDA) process for approving new prescription drugs, especially after the agency allowed a trio of products to reach the market without serious questions about their safety being answered, including the … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuit MDL Established in District of Southern Illinois

Lawsuits alleging the maker of Pradaxa failed to adequately warning users of its association with life-threatening, uncontrolled bleeding have been consolidated in a multidistrict litigation in U.S. District Court, Southern District of Illinois.  All Pradaxa injury lawsuits filed in federal … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bid to Dismiss Pradaxa Bleeding Lawsuits Rejected

A federal judge in Illinois has denied Boehringer Ingelheim Pharmaceuticals motion to dismiss Pradaxa bleeding lawsuits.  The decision by Judge David Herndon in U.S. District Court, Southern District of Illinois, comes as Pradaxa plaintiffs throughout the country wait to hear … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation.  According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

64 More Plavix Patients File Suit Over Bleeding Side Effects

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa.  Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because … Continue reading

Posted in Pharmaceuticals, Pradaxa |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.